State medication access · Selected providers
GLP-1 medication access: online access in the District of Columbia.
Company statements checked September 10, 2026: 1 covered company — Gentle Health — advertises online GLP-1 medication access for patients in the District of Columbia. Confirm eligibility and total charges with the provider.
Company-reported District of Columbia access to Gentle Health's three named compounded semaglutide and tirzepatide programs, with product, first-visit and payment limitations.
Selected product offers advertised for patients in the District of Columbia, not verified local offices, pharmacy stock, appointment slots or prescription guarantees.
Check what the District listing covers
Gentle Health’s coverage statement enumerates the District of Columbia and, for the footprint it lists, names three separate compounded programs: oral semaglutide, injectable semaglutide and injectable tirzepatide. After adding Missouri on September 18, the article described its reach as 40 states plus the District, counting the District in its own right rather than inside a state total.
Their cash-pay prices vary by program and tier, starting at $112, $135 and $169 a month respectively. A listed jurisdiction is not confirmation of pharmacy eligibility, stock or a prescription, and the three programs are not a bundle.
Check the first-visit route before assuming an online intake
The company’s first-visit guide sorts jurisdictions between questionnaire-and-review and scheduled-video routes. The company’s workflow article lists Washington, DC among the jurisdictions where the first visit starts asynchronously, with a questionnaire reviewed by a clinician rather than a scheduled video call. That describes the company’s stated process, not a guarantee: a clinician can still ask for a live conversation, and you should confirm the required steps before paying.
An initial online review can still require further information or a live visit, and the clinician may decline. Ask about the steps for the named product you want; a coverage match does not settle that question for a particular order.
Check what changes at the first shipment request
Gentle Health advertises monthly cash-pay rates starting at $112 for compounded oral semaglutide, $135 for compounded injectable semaglutide and $169 for compounded injectable tirzepatide; higher tiers cost more. Its current terms say the first medication request starts a recurring monthly subscription. Cancellation is available before pharmacy submission or beginning 30 days after the order date once submitted; it stops future billing immediately, but the current billing month’s remainder is not refunded. Pharmacy-stage refunds are handled case by case.
These three programs do not establish access to every GLP-1. All are compounded, not branded medicines or FDA-approved generics; FDA distinguishes compounded drugs from approved drugs. Confirm the cash-pay program and tier quote. The profile and national overview add company and product context, not coverage.
Compare prices
All-in cost for the first 12 weeks at each covered provider, including membership and medication fees, commitments and renewal terms.
More guides for patients in the District of Columbia
Related
- Weight care in the District of Columbia
- Semaglutide in the District of Columbia
- Tirzepatide in the District of Columbia
Other care areas
At a glance
| Company | On this page | Lowest listed monthly figure | Checked | Official site |
|---|---|---|---|---|
| Gentle Health | Compounded oral semaglutide · Compounded injectable semaglutide · Compounded injectable tirzepatide | $112/mo advertised monthly bundle, Compounded oral semaglutide | Official site ↗ |
Selected providers
Which providers offer GLP-1 medication access in the District of Columbia?
1 companies with published profiles and service-specific source records. Listed alphabetically, not ranked. This is selected coverage—not every provider in the market.
Formats describe the program, not a guaranteed first-visit option in every state. A messaging or questionnaire option does not promise an initial evaluation without a live appointment. Read each provider’s service and state access notes.
The monthly cost column adds disclosed medication and required membership charges at each advertised dose and labels each figure an advertised bundle or a known subtotal. Where labs, taxes or other charges are not priced, the figure is not a guaranteed final bill. Cash prices use each provider’s stated monthly billing basis; supplied weeks and upfront commitments can differ. Dose labels identify price tiers, not treatment recommendations.
| Company & service | Program formats & clinicians | Payment & advertised charges | Monthly cost by dose | Access & evidence |
|---|---|---|---|---|
| Gentle Health Gentle Health's separately priced compounded oral semaglutide, injectable semaglutide and injectable tirzepatide programs, if prescribed.
Medical Director: James Simmons, MD — company-reported; see profile for the source. |
The company identifies physician evaluation and online or live-visit workflows. Approval is individual; this is not a treatment recommendation or confirmation of a particular pharmacy's dispensing eligibility. Access channel: Direct to consumer | Cash pay The advertised monthly rates start at $112 for compounded oral semaglutide, $135 for compounded injectable semaglutide and $169 for compounded injectable tirzepatide; higher tiers differ. No separate membership charge is advertised. Current terms allow cancellation before pharmacy submission or beginning 30 days after the order date once submitted. | Compounded oral semaglutide · oral Advertised monthly bundle
Medication, unlimited text and video visits with the doctor, and delivery; the page says the price is the whole price, with no membership fees, shipping fees or added taxes. The page describes these as once-daily drops under the tongue, not Wegovy tablets. Not priced: Patient-specific laboratory testing is not priced on the reviewed page. Billing and introductory offersMonthly price by prescribed dose tier, billed monthly. The order and subscription can be canceled before the order is sent to the pharmacy; once sent, the subscription can be canceled 30 days after the order date, and charges already made, including the current month's, are not prorated or refunded. Price check: . Gentle Health — services, price table and frequently asked questions Compounded injectable semaglutide · injection Advertised monthly bundle
Medication, unlimited text and video visits with the doctor, and delivery; the page says the price is the whole price, with no membership fees, shipping fees or added taxes. Not priced: Patient-specific laboratory testing is not priced on the reviewed page. Billing and introductory offersMonthly price by prescribed dose tier, billed monthly. The order and subscription can be canceled before the order is sent to the pharmacy; once sent, the subscription can be canceled 30 days after the order date, and charges already made, including the current month's, are not prorated or refunded. Price check: . Gentle Health — services, price table and frequently asked questions Compounded injectable tirzepatide · injection Advertised monthly bundle
Medication, unlimited text and video visits with the doctor, and delivery; the page says the price is the whole price, with no membership fees, shipping fees or added taxes. Not priced: Patient-specific laboratory testing is not priced on the reviewed page. Billing and introductory offersMonthly price by prescribed dose tier, billed monthly. The order and subscription can be canceled before the order is sent to the pharmacy; once sent, the subscription can be canceled 30 days after the order date, and charges already made, including the current month's, are not prorated or refunded. Price check: . Gentle Health — services, price table and frequently asked questions | Compounded oral semaglutide — oral: Company-reported District of Columbia coverage for all three named compounded programs, each with separate product evidence. The company's workflow article places Washington, DC in its asynchronous-start group, so the first visit is described as a reviewed questionnaire rather than a scheduled video call. A clinician may still request a live conversation. Coverage does not establish individual approval, pharmacy eligibility or stock. The company names compounded oral semaglutide in the program description for every jurisdiction enumerated on its coverage page, including District of Columbia. This is an advertised compounded product, not a branded or FDA-approved generic offer. The statement does not independently verify pharmacy dispensing eligibility, current stock, clinician approval, individual eligibility or legal clearance for an order. State evidence checked · Product state availability source Compounded injectable semaglutide — injection: Company-reported District of Columbia coverage for all three named compounded programs, each with separate product evidence. The company's workflow article places Washington, DC in its asynchronous-start group, so the first visit is described as a reviewed questionnaire rather than a scheduled video call. A clinician may still request a live conversation. Coverage does not establish individual approval, pharmacy eligibility or stock. The company names compounded injectable semaglutide in the program description for every jurisdiction enumerated on its coverage page, including District of Columbia. This is an advertised compounded product, not a branded or FDA-approved generic offer. The statement does not independently verify pharmacy dispensing eligibility, current stock, clinician approval, individual eligibility or legal clearance for an order. State evidence checked · Product state availability source Compounded injectable tirzepatide — injection: Company-reported District of Columbia coverage for all three named compounded programs, each with separate product evidence. The company's workflow article places Washington, DC in its asynchronous-start group, so the first visit is described as a reviewed questionnaire rather than a scheduled video call. A clinician may still request a live conversation. Coverage does not establish individual approval, pharmacy eligibility or stock. The company names compounded injectable tirzepatide in the program description for every jurisdiction enumerated on its coverage page, including District of Columbia. This is an advertised compounded product, not a branded or FDA-approved generic offer. The statement does not independently verify pharmacy dispensing eligibility, current stock, clinician approval, individual eligibility or legal clearance for an order. State evidence checked · Product state availability source The company's coverage article reports these named compounded programs across 40 states plus DC and names Missouri as the newest addition on September 18. Its Missouri detail page was still being added when rechecked. This does not establish stock or a lawful, clinically suitable order for an individual. Company-reported · Checked
|
No providers match these filters. Try a different payment model or program format.
How companies enter this list
Each listed product has separately reviewed, current product-specific evidence for this state. A company footprint or broad care service cannot establish medication access. Named products, forms and approval categories remain distinct; inclusion is not a claim of interchangeability. The list is selective, not a complete inventory of providers. Inclusion does not establish clinical suitability, state licensure or a currently available appointment.
Smaller and larger providers use the same source requirements and alphabetical ordering. Visit each profile for company history and wider context, or suggest another provider.
Source documents
The table dates show when its claims were checked. Document dates below describe the original sources, where supplied. Additional sources are linked directly in the guide.
- FDA — Concerns with unapproved GLP-1 drugs — U.S. Food and Drug Administration
- Zepbound — Product labeling on DailyMed — Eli Lilly and Company; hosted by the U.S. National Library of Medicine
- Gentle Health — services, price table and frequently asked questions — Gentle Health
- Gentle Health — states served and expansion account — Gentle Health; published
- Gentle Health — Connecticut GLP-1 weight-loss service page — Gentle Health
- Gentle Health — Vermont GLP-1 weight-loss service page — Gentle Health
- Gentle Health — Terms of Service — Gentle Health
- How Gentle Health's Initial Prescribing Process Varies by State — Gentle Health; published